M 274 (Tamoxifen 20 mg)

Pill imprint M 274 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, metastatic; breast cancer, adjuvant; breast cancer; breast cancer, prevention; breast cancer, male (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M 274

Tamoxifen citrate 20 mg M 274 Front
Tamoxifen citrate 20 mg M 274 Back
Tamoxifen citrate 20 mg M 274
Tamoxifen citrate 20 mg M 274
Tamoxifen citrate
Imprint:
M
274
Strength:
20 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0274
Inactive Ingredients:
lactose anhydrous
silicon dioxide
crospovidone
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)